Fig. 1

Regnase-1 expression is negatively correlated with the clinical outcomes and intratumor infiltration of CD11b⁺ cells in PDAC patients. A Representative images of Regnase-1 staining of pancreatic tumors from pancreatic cancer patients. B-C Thirty-nine pancreatic cancer patients were classified into two groups according to the Regnase-1 immunostaining scores in pancreatic tumors. Kaplan–Meier curves of recurrence-free survival (RFS) (B) and overall survival (OS) (C) in each group. D Representative images of CD11b staining of pancreatic tumors in pancreatic cancer patients. E Correlation between Regnase-1 immunostaining scores and CD11b.⁺ cell counts of pancreatic tumors in pancreatic cancer patients. The Pearson product-moment correlation coefficient was used to determine the correlation coefficient. Scale bars: 100 μm (insets)